Grace Therapeutics GRCE
NASDAQ GRCE
$2.20 +0.06 (+2.80%)
As of: Aug 21, 2026 · 1:07 PM EDT

Grace Therapeutics (GRCE) FCF Margin (QoQ) (2021)

Grace Therapeutics (GRCE) FCF Margin (QoQ) (2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.66 Bn 131.80 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.52 Bn 78.53 Bn 3.93 Bn
3 Argenx Se 65.33 Bn 60.14 Bn 1.37 Bn
4 Moderna 59.76 Bn 54.62 Bn 52.00 Mn
5 BeOne Medicines 42.15 Bn 37.05 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.84 Bn 28.53 Bn 992.69 Mn
7 BioNTech SE 28.23 Bn 9.84 Bn 668.28 Mn
8 Insmed 27.52 Bn 26.36 Bn 358.27 Mn
9 Royalty Pharma 27.29 Bn 26.46 Bn -
10 Grace Therapeutics 37.72 Mn 37.72 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 367,203.00